Skip to main content
Staff Login
Username
*
Enter your The Contraceptive Pipeline Database username.
Password
*
Enter the password that accompanies your username.
Log in
Forgot password
Toggle navigation
Evestra Prodrug 6 Month Injectable
Product Overview
Development Status:
Active Development
Target:
Female
Mode:
Hormonal
Delivery Type:
Injectable
Duration Type:
Long-acting
Description:
Evestra is advancing research on a technology that could lead to long-acting injectable fertility control for women by applying its proprietary prodrug platform technology to the development of the product.
Updated date:
July 19, 2016
Vertical Tabs
Product Details
Potential Multi-Purpose Technology (MPT):
No
Regimen:
one injection every 6 months
Duration:
6 months
Partner:
Evestra, Inc.
Status
Project Phase:
Early Development
Status Details:
Received a grant in 2016 from the Bill & Melinda Gates Foundation.
Programmatic Considerations
Considerations:
Evestra, Inc. is committed to advancing fertility control methods for women in under-served regions.
Additional Information
Additional Information:
Evestra, Inc. website
Download Product Report
